Sensitive and reliable detection of Kit point mutation Asp 816 to Val in pathological material

被引:13
作者
Kaehler, Christian [1 ]
Didlaukat, Sabine [1 ]
Feller, Alfred C. [1 ]
Merz, Hartmut [1 ]
机构
[1] Med Univ Lubeck, Inst Pathol, D-23538 Lubeck, Germany
关键词
Prime Combination; Mastocytosis; FFPE Sample; Additional Mismatch; Constitutive Tyrosine Kinase Activation;
D O I
10.1186/1746-1596-2-37
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: Human mastocytosis is a heterogenous disorder which is linked to a gain-of-function mutation in the kinase domain of the receptor tyrosine kinase Kit. This D816V mutation leads to constitutive activation and phosphorylation of Kit with proliferative disorders of mast cells in the peripheral blood, skin, and spleen. Most PCR applications used so far are labour-intensive and are not adopted to daily routine in pathological laboratories. The method has to be robust and working on such different materials like archival formalin-fixed, paraffin-embedded tissue (FFPE) and blood samples. Such a method is introduced in this publication. Methods: The Kit point mutation Asp 816 to Val is heterozygous which means a problem in detection by PCR because the wild-type allele is also amplified and the number of cells which bear the point mutation is in most of the cases low. Most PCR protocols use probes to block the wildtype allele during amplification with more or less satisfying result. This is why point-mutated forward primers were designed and tested for efficiency in amplification of the mutated allele. Results: One primer combination (A) fits the most for the introduced PCR assay. It was able just to amplify the mutated allele with high specificity from different patient's materials (FFPE or blood) of varying quality and quantity. Moreover, the sensitivity for this assay was convincing because 10 ng of DNA which bears the point mutation could be detected in a total volume of 200 ng of DNA. Conclusion: The PCR assay is able to deal with different materials (blood and FFPE) this means quality and quantity of DNA and can be used for high-througput screening because of its robustness. Moreover, the method is easy-to-use, not labour-intensive, and easy to realise in a standard laboratory.
引用
收藏
页数:5
相关论文
共 13 条
[1]   Allele-specific polymerase chain reaction for the imatinib-resistant KIT D816V and D816F mutations in mastocytosis and acute myelogenous leukemia [J].
Corless, Christopher L. ;
Harrell, Patina ;
Lacouture, Mario ;
Bainbridge, Troy ;
Le, Claudia ;
Gatter, Ken ;
White, Clifton, Jr. ;
Granter, Scott ;
Heinrich, Michael C. .
JOURNAL OF MOLECULAR DIAGNOSTICS, 2006, 8 (05) :604-612
[2]   MASTOCYTOSIS [J].
FINE, JD .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1980, 19 (03) :117-123
[3]   IDENTIFICATION OF MUTATIONS IN THE CODING SEQUENCE OF THE PROTOONCOGENE C-KIT IN A HUMAN MAST-CELL LEUKEMIA-CELL LINE CAUSING LIGAND-INDEPENDENT ACTIVATION OF C-KIT PRODUCT [J].
FURITSU, T ;
TSUJIMURA, T ;
TONO, T ;
IKEDA, H ;
KITAYAMA, H ;
KOSHIMIZU, U ;
SUGAHARA, H ;
BUTTERFIELD, JH ;
ASHMAN, LK ;
KANAYAMA, Y ;
MATSUZAWA, Y ;
KITAMURA, Y ;
KANAKURA, Y .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (04) :1736-1744
[4]   Changes in concentration of DNA in serum and plasma during storage of blood samples [J].
Jung, M ;
Klotzek, S ;
Lewandowski, M ;
Fleischhacker, M ;
Jung, K .
CLINICAL CHEMISTRY, 2003, 49 (06) :1028-1029
[5]   EFFECTS OF PRIMER TEMPLATE MISMATCHES ON THE POLYMERASE CHAIN-REACTION - HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 MODEL STUDIES [J].
KWOK, S ;
KELLOGG, DE ;
MCKINNEY, N ;
SPASIC, D ;
GODA, L ;
LEVENSON, C ;
SNINSKY, JJ .
NUCLEIC ACIDS RESEARCH, 1990, 18 (04) :999-1005
[6]   Normal and oncogenic forms of the receptor tyrosine kinase kit [J].
Lennartsson, J ;
Jelacic, T ;
Linnekin, D ;
Shivakrupa, R .
STEM CELLS, 2005, 23 (01) :16-43
[7]   Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis [J].
Longley, BJ ;
Metcalfe, DD ;
Tharp, M ;
Wang, XM ;
Tyrrell, L ;
Lu, SZ ;
Heitjan, D ;
Ma, YS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (04) :1609-1614
[8]   IDENTIFICATION OF A POINT MUTATION IN THE CATALYTIC DOMAIN OF THE PROTOONCOGENE C-KIT IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS OF PATIENTS WHO HAVE MASTOCYTOSIS WITH AN ASSOCIATED HEMATOLOGIC DISORDER [J].
NAGATA, H ;
WOROBEC, AS ;
OH, CK ;
CHOWDHURY, BA ;
TANNENBAUM, S ;
SUZUKI, Y ;
METCALFE, DD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (23) :10560-10564
[9]   SINGLE-BASE PAIR MUTATION ANALYSIS BY PNA DIRECTED PCR CLAMPING [J].
ORUM, H ;
NIELSEN, PE ;
EGHOLM, M ;
BERG, RH ;
BUCHARDT, O ;
STANLEY, C .
NUCLEIC ACIDS RESEARCH, 1993, 21 (23) :5332-5336
[10]   One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes [J].
Sotlar, K ;
Escribano, L ;
Landt, F ;
Möhrle, S ;
Herrero, S ;
Torrelo, A ;
Lass, U ;
Horny, HP ;
Bültmann, B .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (03) :737-746